FierceBiotech ٢١ أبريل ٢٠٢٦ Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
FierceBiotech ١٦ أبريل ٢٠٢٦ Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech ٦ أبريل ٢٠٢٦ With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine
FierceBiotech ١ أبريل ٢٠٢٦ Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
FierceBiotech ١ أبريل ٢٠٢٦ Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down
FierceBiotech ٢٣ مارس ٢٠٢٦ Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
FierceBiotech ١٢ مارس ٢٠٢٦ Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
FierceBiotech ٤ مارس ٢٠٢٦ Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations
FierceBiotech ٢٥ فبراير ٢٠٢٦ After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
FierceBiotech ٦ فبراير ٢٠٢٦ Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
FierceBiotech ٤ فبراير ٢٠٢٦ Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
FierceBiotech ٢١ يناير ٢٠٢٦ Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
FierceBiotech ٩ يناير ٢٠٢٦ Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
FierceBiotech ٩ ديسمبر ٢٠٢٥ Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
FierceBiotech ٥ ديسمبر ٢٠٢٥ Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability